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Figure 1 (A) Post-gadolinium sagittal MR image showing a
sellar—suprasellar mass with marked heterogeneous enhance-
ment of the mass and pituitary stalk. (B) High powered micro-
scopic view (H&E staining,40) of the excised specimen showing
dense aggregates of lymphoid cells with occasional plasma cells
around a few ill-defined granulomas composed of epitheloid cells
and Langhans-type multinucleated giant cells mixed with normal
pituitary tissue on the left.Pituitary tuberculosis presenting as pituitary
apoplexy
Pituitary tuberculosis (TB) is an uncommon form of intra-
cranial TB. Isolated pituitary TB in the absence of other
forms of intracranial or systemic TB is extremely rare and
difficult to diagnose. Very few cases of isolated pituitary
TB are documented in the literature.1—5 They usually mimic
a pituitary adenoma. Until now only one case has been
reported presenting with ‘pituitary apoplexy’.6 We report
another case of pituitary TB presenting with sudden
onset headaches and neuro-deficits mimicking a pituitary
apoplexy.
A 27-year-old female patient, living in Kolkata, India
presented with a history of sudden onset of headaches
followed by left ptosis and left facial numbness. She had
no history of pulmonary or systemic TB. On examination she
was found to be drowsy and obtunded. She had tachycardia
(pulse 92/min) but her blood pressure was normal. Her
Glasgow Coma Score was 13 (E3, M6, V4). She had left-sided
complete ptosis and her direct and consensual pupillary
reflexes were normal on both sides. There were no obvious
visual field defects on bedside testing. She had left facial
hypoesthesia in left V1 and V2 distribution. She had no other
neuro-deficits or signs of endocrine disturbances. Her hor-
mone profile did not reveal any abnormality except margin-
ally elevated prolactin levels (150 mIU/L). Computerized
tomography (CT) scan showed a sellar and suprasellar mass
with evidence of hemorrhage that was enhancing brightly
on contrast. A magnetic resonance imaging (MRI) scan
showed well-defined sellar mass with suprasellar extension
that was heterogeneously hyperintense on T-2-weighted
images and there was marked heterogeneous enhancement
of the mass and pituitary stalk on post-gadolinium scan
(Figure 1A). With an initial diagnosis of pituitary adenoma
with apoplexy, the patient underwent trans-sphenoidal
excision of the pituitary tumor. Intra-operatively, the sellar
mass was firm, gray, fibrous and densely adherent to the
surrounding structures and was partially excised. Histo-
pathology showed dense aggregates of lymphoid cells with
occasional plasma cells around a few ill-defined granulomas
composed of epitheloid cells and Langhans’ type multi-
nucleated giant cells (Figure 1B). There was no evidence
of acid-fast bacilli (AFB) and AFB culture was negative.
Histological diagnosis was that of granulomatous inflamma-
tion of pituitary suggestive of tuberculosis. These histolo-
gical findings coupled with pituitary stalk thickening on the
post-contrast MRI and the fact that the patient lived in a TB
endemic area pointed towards a diagnosis of pituitary TB
rather than lymphocytic hypophysitis or sarcoidosis. The
post-operative course was uneventful except for a transient
diabetes insipidus. She was started on anti-TB medication
after histological diagnosis. Her ptosis and numbness
improved completely within three weeks after operation.
A post-operative hormone profile repeated after 6 months
was normal and follow-up MRI showed complete resolution
of the granuloma.
Though tuberculomas form 0.15 to 4% of all intracranial
lesions, isolated pituitary TB is rare. Clinically and radiolo-
gically, it is difficult to distinguish pituitary tuberculomas
from pituitary adenomas. A history of extracranial tubercu-
losis in the past associated with radiological findings likeleptomeningeal enhancement, parenchymatous brain tuber-
culomas or a thickened pituitary stalk on contrast MRI, are
indicative of the possibility of pituitary tuberculosis.3 Pitui-
tary TB presenting as ‘apoplexy-like’ symptoms has only been
reported once before in the literature.6 Pituitary apoplexy is
seen in 6 to 10% of all pituitary tumors and presents with
intense headaches, sudden neurological deficits like ptosis or
visual impairment and altered sensorium.7 In these patients
early surgical decompression is warranted as it prevents
persistent neuro-ophthalmic deficit. It is well documented
that the efficacy of surgery for the relief of neuro-ophthalmic
symptoms decreases with increasing duration of symptoms.8
It has been speculated that tuberculous vasculitis can cause
ischemic or hemorrhagic necrosis in the tuberculoma, pitui-
tary gland or adjacent tissue and could give rise to these
symptoms.6 The main role of surgery in pituitary TB is to
achieve diagnosis and decompression3,6,9 and the preferred
route is trans-sphenoidal.9,10 Histologically the differential
diagnoses of intrasellar granulomas include lymphocytic
hypophysitis, sarcoidosis or Langerhans’ histiocytosis.11
Trans-sphenoidal excision followed by a proper histological
diagnosis and long-term anti-TB chemotherapy generally
leads to a good outcome.
Letters to the Editor 339In conclusion, pituitary TB presenting as pituitary apo-
plexy is very rare. This is only the second case reported in the
literature. A high index of clinical suspicion of pituitary TB is
warranted in endemic areas, even when the patient presents
with apoplexy-like symptoms.References
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infection in neutropenic patients successfully
treated with a combination of polymyxin B and
rifampin
Gram-negative bacillary infection remains a threat to
patients who become neutropenic after treatment for a
hematologic malignancy or stem cell transplantation, espe-
cially when the organism is resistant to multiple antibiotics.
Between May and December 2003, we saw four cases of
infection due to multidrug-resistant Pseudomonas aerugi-
nosa (MRPA) susceptible in vitro only to polymyxin B. This
drug acts synergistically in vitro with rifampin against multi-
drug-resistant Gram-negative bacilli, including Pseudomo-
nas aeruginosa.1,2 In a previous study, eight out of 12
patients who were infected by multidrug-resistant Serratia
marcescens were cured by this antibiotic combination.3
We therefore decided to try this treatment for two cases
of MRPA.
Patient A developed phlebitis and cellulitis accompanied
by high fever during the recovery phase of neutropenia, and
MRPA bacteremia was detected (Table 1). Treatment with
polymyxin B (1.0 mg/kg IV q12h) and rifampin (10 mg/kg IV
q12h) was commenced. Within a few hours she was admitted
to the ICU due to septic shock and respiratory failure resem-
bling acute respiratory distress syndrome, which necessi-
tated mechanical ventilation. Blood culture yielded MRPA24 hours after starting therapy but was sterile thereafter.
The phlebitis resolved, and she was weaned off vasopressors
andmechanical ventilation 12 and 14 days later, respectively.
This antibiotic combination was administered for 19 days and
was well tolerated.
Patient B had extensive cellulitis of the scalp with high
fever while being severely neutropenic. A specimen of pus
yielded MRPA on day 10. Polymyxin B (1.0 mg/kg IV q12h)
and rifampin (10 mg/kg IV q12h) were prescribed. The high
fever and scalp infection resolved. Granulocytes recovered
on day 17 of granulocyte colony-stimulating factor (G-CSF)
therapy. The antibiotic combination was administered for
21 days.
Treatment was well tolerated and toxicity was reduced by
employing saline hyperhydration (3 L/m2) in both cases, even
though its protective effect has not been proven. Previous
studies of critically ill patients have also shown a good
tolerance for polymyxin B.4,5 In both cases there was a
transient elevation of bilirubin up to 6 mg/dL during rifampin
administration that was reversed after the end of the treat-
ment.
The duration of polymyxin B—rifampin combination ther-
apy in this setting should be based on hematological recovery,
clinical response, and microbiological results.
These results suggest that the combination of polymyxin
B—rifampin is worth exploring further for treating neutro-
penic patients who develop infections due to multiply-resis-
tant P. aeruginosa.
